Litcius/Paper detail

Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells

Zahra Molaei, Zahra Jabbarpour, Azadeh Omidkhoda, Naser Ahmadbeigi

2024Stem Cell Research & Therapy12 citationsDOIOpen Access PDF

Abstract

Gene manipulation of hematopoietic stem cells (HSCs) using the CRISPR/Cas system as a potent genome editing tool holds immense promise for addressing hematologic disorders. An essential hurdle in advancing this treatment lies in effectively delivering CRISPR/Cas to HSCs. While various delivery formats exist, Ribonucleoprotein complex (RNP) emerges as a particularly efficient option. RNP complexes offer enhanced gene editing capabilities, devoid of viral vectors, with rapid activity and minimized off-target effects. Nevertheless, novel delivery methods such as microfluidic-based techniques, filtroporation, nanoparticles, and cell-penetrating peptides are continually evolving. This study aims to provide a comprehensive review of these methods and the recent research on delivery approaches of RNP complexes to HSCs.

Topics & Concepts

CRISPRRibonucleoproteinGenome editingStem cellHaematopoiesisComputational biologyGene deliveryBiologyHematopoietic stem cellGeneCell biologyGenetic enhancementGeneticsRNACRISPR and Genetic EngineeringVirus-based gene therapy researchViral Infections and Immunology Research